113 related articles for article (PubMed ID: 23340201)
1. New nicotinic analogue ZY-1 enhances cognitive functions in a transgenic mice model of Alzheimer's disease.
Nie H; Wang Z; Zhao W; Lu J; Zhang C; Lok K; Wang Y; Shen H; Xu Z; Yin M
Neurosci Lett; 2013 Mar; 537():29-34. PubMed ID: 23340201
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
[TBL] [Abstract][Full Text] [Related]
3. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.
Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS
Curr Opin Investig Drugs; 2008 Jan; 9(1):47-56. PubMed ID: 18183531
[TBL] [Abstract][Full Text] [Related]
4. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
5. Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Rangani RJ; Upadhya MA; Nakhate KT; Kokare DM; Subhedar NK
Peptides; 2012 Feb; 33(2):317-28. PubMed ID: 22266216
[TBL] [Abstract][Full Text] [Related]
6. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S; Maskos U
Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics.
Scott Bitner R
Biochem Pharmacol; 2012 Mar; 83(6):705-14. PubMed ID: 22119240
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
Mousavi M; Hellström-Lindahl E
Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
[TBL] [Abstract][Full Text] [Related]
9. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
[TBL] [Abstract][Full Text] [Related]
10. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against extracellular domains of α4 and α7 subunits alter the levels of nicotinic receptors in the mouse brain and affect memory: possible relevance to Alzheimer's pathology.
Lykhmus O; Koval L; Skok M; Zouridakis M; Zisimopoulou P; Tzartos S; Tsetlin V; Granon S; Changeux JP; Komisarenko S; Cloëz-Tayarani I
J Alzheimers Dis; 2011; 24(4):693-704. PubMed ID: 21321393
[TBL] [Abstract][Full Text] [Related]
12. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
[TBL] [Abstract][Full Text] [Related]
13. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
Bontempi B; Whelan KT; Risbrough VB; Rao TS; Buccafusco JJ; Lloyd GK; Menzaghi F
J Pharmacol Exp Ther; 2001 Oct; 299(1):297-306. PubMed ID: 11561092
[TBL] [Abstract][Full Text] [Related]
14. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Hernandez CM; Terry AV
Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
[TBL] [Abstract][Full Text] [Related]
15. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
Ni R; Marutle A; Nordberg A
J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease.
Chen SG; Gu RX; Dai H; Wei DQ
J Mol Graph Model; 2013 Feb; 39():98-107. PubMed ID: 23261879
[TBL] [Abstract][Full Text] [Related]
17. SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist.
Haydar SN; Ghiron C; Bettinetti L; Bothmann H; Comery TA; Dunlop J; La Rosa S; Micco I; Pollastrini M; Quinn J; Roncarati R; Scali C; Valacchi M; Varrone M; Zanaletti R
Bioorg Med Chem; 2009 Jul; 17(14):5247-58. PubMed ID: 19515567
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
[TBL] [Abstract][Full Text] [Related]
19. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
